New drug could slow the development of Alzheimer's

MedicalXpress | 六月 08, 2026

"Compound 10" is how Ursula Quitterer refers to the chemical compound that her team has developed and that could slow the progression of Alzheimer's disease. Quitterer is a professor of molecular pharmacology at ETH Zurich and has so far tested the active ingredient first in mice, revealing promising effects: The typical death of nerve cells seen in dementia is significantly slower, and the animals survive longer.